AMTX vs. LNZA, CDXS, FF, ORGN, GEVO, VGAS, ALTO, GAMC, LODE, and TOMZ
Should you be buying Aemetis stock or one of its competitors? The main competitors of Aemetis include LanzaTech Global (LNZA), Codexis (CDXS), FutureFuel (FF), Origin Materials (ORGN), Gevo (GEVO), Verde Clean Fuels (VGAS), Alto Ingredients (ALTO), Golden Arrow Merger (GAMC), Comstock (LODE), and TOMI Environmental Solutions (TOMZ). These companies are all part of the "industrial organic chemicals" industry.
Aemetis (NASDAQ:AMTX) and LanzaTech Global (NASDAQ:LNZA) are both small-cap oils/energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, community ranking, dividends, earnings, profitability and institutional ownership.
Aemetis has higher revenue and earnings than LanzaTech Global. LanzaTech Global is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.
Aemetis has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, LanzaTech Global has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500.
In the previous week, LanzaTech Global had 3 more articles in the media than Aemetis. MarketBeat recorded 6 mentions for LanzaTech Global and 3 mentions for Aemetis. Aemetis' average media sentiment score of 0.98 beat LanzaTech Global's score of 0.58 indicating that Aemetis is being referred to more favorably in the media.
Aemetis has a net margin of -17.20% compared to LanzaTech Global's net margin of -152.29%. Aemetis' return on equity of 0.00% beat LanzaTech Global's return on equity.
Aemetis received 167 more outperform votes than LanzaTech Global when rated by MarketBeat users. However, 87.50% of users gave LanzaTech Global an outperform vote while only 60.42% of users gave Aemetis an outperform vote.
Aemetis currently has a consensus target price of $10.40, suggesting a potential upside of 201.45%. LanzaTech Global has a consensus target price of $6.33, suggesting a potential upside of 138.99%. Given Aemetis' higher probable upside, equities analysts clearly believe Aemetis is more favorable than LanzaTech Global.
27.0% of Aemetis shares are held by institutional investors. Comparatively, 17.8% of LanzaTech Global shares are held by institutional investors. 14.3% of Aemetis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Aemetis beats LanzaTech Global on 10 of the 16 factors compared between the two stocks.
Get Aemetis News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
